Malin Life Sciences Holdings Ltd, 10% Owner at Poseida Therapeutics, Inc. (PSTX), bought 2,150,000 shares at $3.50 ($7.5M) on 2022-08-08, disclosed to the SEC on 2022-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| PSTX | BUY | 2021-11-29 | $531K | — | Filing → |
| PSTX | BUY | 2021-11-23 | $363K | — | Filing → |
| PSTX | BUY | 2021-11-18 | $5.5M | — | Filing → |